Vertex Pharmaceuticals Inc.

Insight from Louise Proulx, Ex-Vice President and General Manager, Vertex Pharmaceuticals

“Among the arguments used to convince our company’s management to invest in our team’s know-how, I emphasized the Greater Montréal cluster’s assets, partnership opportunities and quality of research. In spite of recent changes in big pharma’s business model, these strengths remain. I believe that to continue to develop, we will have to rely on our institutions that have earned international recognition in areas such as cardiology and neurology as well as specialties in which we are already on the cutting-edge.”

Louise Proulx, Ex-Vice President and General Manager, Vertex Pharmaceuticals